Preventive PCI versus only optimal medical therapy for vulnerable plaques
Marc Bonaca, MD
Self-assessment on statin eligibility without prescription using a web app
Steven Nissen, MD
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Erik Stroes, MD, PhD
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
Michael Gibson, MD
Loading...
We’re glad to see you’re enjoying PACE-CME…but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.